Does caffeine reduce rosuvastatin-induced protection against ischemia-reperfusion injury?

Trial Profile

Does caffeine reduce rosuvastatin-induced protection against ischemia-reperfusion injury?

Completed
Phase of Trial: Phase II

Latest Information Update: 19 Aug 2009

At a glance

  • Drugs Rosuvastatin (Primary) ; Caffeine
  • Indications Hyperlipidaemia
  • Focus Pharmacodynamics
  • Most Recent Events

    • 19 Aug 2009 Status changed from recruiting to completed.
    • 01 Jun 2009 Results published in Arteriosclerosis Thrombosis and Vascular Biology.
    • 09 Oct 2007 Status change from initiated to recruiting
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top